Skip to main content
Livermore
Livermore
ZHEN

Esperion Therapeutics, Inc.

ESPRDelisted Jul 13, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001434868

Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 191 institutions reported holding it in 13F filings for Q2 2026, worth $646.8M in total; Soros Fund Management was the only superinvestor holding it.

Q2 2024 vs. Q1 2024

How the institutions holding Esperion Therapeutics, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of ESPR: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders1522176+26
Shares125.5M52.5K137.0M+11.6M (+9.3%)
Value$336.2M$140.8K$304.2M−$31.8M (−9.5%)

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (56)

Institutions that held Esperion Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to ESPR in Q2 2024
InstitutionSharesValue% of portfolio
Whitefort Capital Management, LP2,299,121$5.10M3.15%
Nuveen Asset Management, LLC2,272,628$5.05M0.00%
Rhenman & Partners Asset Management AB1,975,000$4.38M0.42%
CenterBook Partners LP1,569,459$3.48M0.22%
Deutsche Bank AG1,532,123$3.40M0.00%
Connor, Clark & Lunn Investment Management Ltd.415,900$923.3K0.00%
Graham Capital Management, L.P.341,890$759.0K0.03%
CWM Advisors, LLC341,223$757.5K0.09%
Headlands Technologies LLC276,260$613.3K0.07%
Highbridge Capital Management LLC254,265$564.5K0.02%
Alpine Global Management, LLC183,922$408.3K0.07%
CI Private Wealth, LLC182,500$405.1K0.00%
Alliancebernstein L.P.182,110$404.3K0.00%
Pentwater Capital Management LP181,290$402.5K0.01%
Virtus ETF Advisers LLC113,178$251.3K0.12%
Corebridge Financial, Inc.101,658$226.7K0.00%
Simplex Trading, LLC91,844$203.0K0.01%
New York State Common Retirement Fund76,500$169.8K0.00%
Manufacturers Life Insurance Company, The71,488$158.7K0.00%
Deerfield Management Company, L.P. (Series C)66,588$147.8K0.00%
State of Wyoming65,716$145.9K0.02%
Voya Investment Management LLC63,029$139.9K0.00%
Midland Wealth Advisors LLC60,000$133.2K0.01%
Baader Bank INC60,216$131.5K0.01%
MetLife Investment Management48,316$107.3K0.00%
Oxford Asset Management LLP42,161$93.6K0.09%
Davenport & Co LLC30,000$66.6K0.00%
Castleview Partners, LLC27,374$60.8K0.03%
American Century Companies Inc22,518$50.0K0.00%
Creative Planning20,597$45.7K0.00%
Sivia Capital Partners, LLC20,000$44.4K0.03%
Ameritas Investment Partners, Inc.18,512$41.1K0.00%
LPL Financial LLC17,548$39.0K0.00%
Legal & General Group Plc17,541$38.7K0.00%
Dynamic Technology Lab Private Ltd17,007$38.0K0.00%
Gotham Asset Management, LLC15,271$33.9K0.00%
California State Teachers Retirement System13,692$30.4K0.00%
Janney Montgomery Scott LLC13,550$30.0K0.00%
Xponance, Inc.12,445$27.6K0.00%
MML Investors Services, LLC12,047$27.0K0.00%
Sigma Planning Corp12,141$27.0K0.00%
Bokf, NA11,905$26.4K0.00%
Lazard Asset Management LLC11,694$25.0K0.00%
Baxter Bros Inc11,000$24.4K0.00%
Texas Capital Bank Wealth Management Services Inc10,000$22.2K0.00%
Geneos Wealth Management Inc.7,150$15.9K0.00%
Amalgamated Bank6,538$15.0K0.00%
Hoertkorn Richard Charles2,000$4.44K0.00%
Steward Partners Investment Advisory, LLC1,000$2.22K0.00%
Manchester Capital Management LLC450$9990.00%
Quadrant Capital Group LLC435$9660.00%
Signaturefd, LLC342$7590.00%
Brown, Lisle/Cummings, Inc.190$4220.00%
TD Waterhouse Canada Inc.59$1380.00%
Rothschild Investment LLC60$1330.00%
Harbour Investments, Inc.39$870.00%

Sold out (30)

Institutions that held Esperion Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of ESPR in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
OrbiMed Advisors LLC13,708,731$36.7M
HRT Financial LP442,030$1.18M
Man Group plc440,770$1.18M
Squarepoint Ops LLC300,300$804.8K
Cubist Systematic Strategies, LLC273,292$732.4K
Walleye Capital LLC227,630$610.0K
Susquehanna Fundamental Investments, LLC166,457$446.1K
Balyasny Asset Management LLC159,038$426.2K
UBS Oconnor LLC142,418$381.7K
Point72 Asia (Singapore) Pte. Ltd.114,371$306.5K
Susquehanna Portfolio Strategies, LLC92,300$247.4K
Russell Investments Group, Ltd.84,367$226.1K
Brevan Howard Capital Management LP69,025$185.0K
Jefferies Financial Group Inc.63,500$170.2K
Bayesian Capital Management, LP51,200$137.2K
Tudor Investment Corp Et Al43,214$115.8K
Jump Financial, LLC38,762$103.9K
CTC Alternative Strategies, Ltd.37,100$99.4K
Omers Administration Corp32,200$86.3K
Tower Research Capital LLC (TRC)32,173$86.2K
Kingsview Wealth Management, LLC25,000$67.0K
LMR Partners LLP23,330$62.5K
Y-Intercept (Hong Kong) Ltd18,267$49.0K
Nebula Research & Development LLC13,974$37.5K
CVI Holdings, LLC13,734$36.8K
State Board of Administration of Florida Retirement System18,471$29.4K
First Manhattan Co1,000$2.68K
Macquarie Group Ltd9,215$25
Assetmark, Inc8$21
Elequin Capital LP1$3

Not filed for Q2 2024 yet (2)

Institutions that held Esperion Therapeutics, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ESPR in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Eaton Financial Holdings Company, LLC34,030$91.2K
Credit Suisse AG18,517$49.6K